David Ross

49PUBLICATIONS

216CO-AUTHORS

Haematological tumoursGene and molecular therapyPredictive and prognostic markersMolecular targetsRegenerative medicine (incl. stem cells)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (49)

Sort by Publication Date:

|May 08, 2026

Single cell long read genotyping of transcripts reveals discrete mechanisms of clonal evolution in post-MPN AML.

|Apr 29, 2026

The lysine-specific demethylase 1 (LSD1) inhibitor bomedemstat in myelofibrosis: results from a phase 1/2 study.

|Mar 05, 2026

Genomic profiling for decision-making in post-polycythemia vera and post-essential thrombocythemia myelofibrosis.

Barbara Mora, Francesca Palandri, Paola Guglielmelli

|Feb 27, 2026

Phase 2 study of the lysine-specific demethylase 1 inhibitor bomedemstat for essential thrombocythemia.

Harinder Gill, Francesca Palandri, David M Ross

|Jan 05, 2026

Prediction of relapse after discontinuation of tyrosine kinase inhibitor treatment in CML.

David M Ross

|Sep 27, 2025

Lipid Storage and Therapy Resistance in Chronic Myeloid Leukaemia: A Novel Perspective on Targeting Metabolic Vulnerabilities.

Molly Tolland, David M Ross, Deborah White

Pageof 9

Frequent Collaborators

8 joint publications

Naranie Shanmuganathan

Susan Branford

Anna L Brown

Christopher N Hahn

Alessandro M Vannucchi

Francesco Passamonti

Agnes Sm Yong

Timothy P Hughes

Francesca Palandri

Hamish Scott

Frequent Collaborators

8 joint publications

Naranie Shanmuganathan

7 joint publications

Susan Branford

6 joint publications

Anna L Brown

5 joint publications

Christopher N Hahn